Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: Impact on posttransplant outcome

Liver Transplantation

Volumn 10, Issue 1, 2004, Pages 115-122

  Keaveny, Andrew Paul ^a   Gordon, Fredric David ^a,b   Goldar Najafi, Atoussa ^c,d   Lewis, William David ^a,b   Pomfret, Elizabeth Anne ^a,b   Pomposelli, James John ^a,b   Jenkins, Roger Lewin ^a,b   Khettry, Urmila ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT BYPASS; BILE DUCT DISEASE; CHOLECYSTECTOMY; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER HILUS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL; TREATMENT OUTCOME; XANTHOGRANULOMA;

ADULT; CHOLANGITIS, SCLEROSING; GRAFT SURVIVAL; GRANULOMA; HUMANS; LIVER; LIVER TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; TREATMENT OUTCOME; XANTHOMATOSIS;

EID: 3042732125     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20005     Document Type: Article

References (13)

1. Roberts KM, Parsons MA. Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases. J Clin Pathol 1987;40: 412-417.
2. Ordonez NG, Rosai J. Urinary tract. In: Rosai J, ed. Ackerman's surgical pathology. St. Louis: Mosby Year Book; 1996:1059-1084.
3. Goldar-Najafi A, Khettry U. Xanthogranulomatous choledochitis: a previously undescribed mass lesion of the hepatobiliary and ampullary region. Semin Liver Dis 2003;23:101-106.
4. Portmann BC, Nakanuma Y. Diseases of the bile ducts. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the liver. 4th ed. London: Churchill Livingstone; 2002:435-506.
5. Khettry U, Keaveny AP, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, et al. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol 2003 (in press).
6. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
7. Terminology for hepatic allograft rejection. International Working Party. Hepatology 1995;22:648-654.
8. Demetris AJ, Tsamandas AC, Delaney CP, Abu-Dlmagd K, Fung JJ, Starzl TE. Pathology of liver transplantation. In: Busuttil R, Klintmalm GB, eds. Transplantation of the liver. Philadelphia: W.B. Saunders; 1996;681-723.
9. Sauerbruch T, Holl J, Ruckdeschel G, Forstl J, Weinzierl M. Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy 1985;17:170-172.
10. Katabi N, Albores-Saavedra J. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis. Am J Surg Pathol 2003;27:349-355.
11. Harrison RF, Hubscher SG. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology 1991; 19:321-327.
12. Saldeen K, Friman S, Olausson M, Olsson R. Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis. Scand J Gastroenterol 1999; 34:535-540.
13. Liden H, Norrby J, Friman S, Olausson M. Liver transplantation for primary sclerosing cholangitis - a single-center experience. Transpl Int 2000;13(suppl 1):S162-164.